全文获取类型
收费全文 | 960篇 |
免费 | 4篇 |
专业分类
林业 | 50篇 |
农学 | 2篇 |
147篇 | |
综合类 | 227篇 |
农作物 | 19篇 |
水产渔业 | 7篇 |
畜牧兽医 | 484篇 |
植物保护 | 28篇 |
出版年
2012年 | 86篇 |
2011年 | 89篇 |
2010年 | 14篇 |
2009年 | 5篇 |
2008年 | 88篇 |
2007年 | 78篇 |
2006年 | 72篇 |
2005年 | 72篇 |
2004年 | 56篇 |
2003年 | 61篇 |
2002年 | 48篇 |
2001年 | 32篇 |
2000年 | 65篇 |
1999年 | 25篇 |
1998年 | 8篇 |
1997年 | 12篇 |
1996年 | 2篇 |
1995年 | 11篇 |
1994年 | 14篇 |
1993年 | 10篇 |
1992年 | 3篇 |
1991年 | 9篇 |
1990年 | 9篇 |
1989年 | 17篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1973年 | 2篇 |
1954年 | 7篇 |
1938年 | 2篇 |
1936年 | 3篇 |
1934年 | 2篇 |
1933年 | 2篇 |
1932年 | 3篇 |
1929年 | 2篇 |
1918年 | 1篇 |
1917年 | 1篇 |
1915年 | 1篇 |
1912年 | 1篇 |
1911年 | 1篇 |
1906年 | 2篇 |
1905年 | 1篇 |
1904年 | 1篇 |
1899年 | 1篇 |
1886年 | 1篇 |
1881年 | 1篇 |
排序方式: 共有964条查询结果,搜索用时 62 毫秒
3.
4.
This paper examines the views of members of the veterinary profession towards the change in orientation of professional practice that is occurring. It contrasts the values of veterinarians with those of doctors, dentists, lawyers and accountants. Particular attention is given to the areas of business efficiency, competition and advertising. Data was derived from self-completion questionnaires containing 40 Likert scales which were mailed to 300 members of each of the five professions. 相似文献
5.
6.
Hill D Correa MT Stevens JB 《Veterinary clinical pathology / American Society for Veterinary Clinical Pathology》1994,23(3):73-75
Azostix-reagent-tests(R) strips (Ames, Miles, Inc., Diagnostic Division, Elkhart, IN) were used to measure blood urea nitrogen values in blood samples from 125 dogs and cats at the North Carolina State University, College of Veterinary Medicine. Results of the tests were compared with standard serum urea nitrogen results. Sensitivity, specificity, and negative predictive values were high (86.4, 90.3, and 96.5%, respectively). Positive predictive value was low, 65.5% of the dogs and cats with elevated blood urea nitrogen values were correctly classified as abnormal The test performs well when the prevalence of abnormal values is near 50%. 相似文献
7.
8.
Savini G Ronchi GF Leone A Ciarelli A Migliaccio P Franchi P Mercante MT Pini A 《Veterinary microbiology》2007,124(1-2):140-146
Because no suitable products are at the moment available to safely control the spread of BTV-16 in Europe, an inactivated vaccine was produced from the reference field isolate of bluetongue virus serotype 16. One group of six sheep was vaccinated subcutaneously with the inactivated vaccine twice, on days 0 and 28, whereas a second group of eight sheep was inoculated with saline solution and used as mock-vaccinated control animals. Seventy-eight days after the first vaccination, all sheep were inoculated subcutaneously with a suspension containing 10(6.3) TCID(50) of a virulent reference BTV-16 isolate. Apart from a transient inflammatory reaction at the injection site, no adverse effects were reported following vaccination. All vaccinated animals developed high titres (7.3-9.3log(2)(ED50%/50 microl)) of virus-specific neutralising antibodies and were resistant to challenge with BTV-16. Conversely, following challenge, control animals developed hyperthermia and long lasting high-titre viraemia. 相似文献
9.
Long MT Gibbs EP Mellencamp MW Zhang S Barnett DC Seino KK Beachboard SE Humphrey PP 《Equine veterinary journal》2007,39(6):486-490
REASON FOR PERFORMING STUDY: West Nile virus (WNV) infection is endemic and able to cause disease in naive hosts. It is necessary therefore to evaluate the safety of new vaccines. OBJECTIVES: To establish: 1) the safety of a modified live Flavivirus/West Nile virus (WN-FV) chimera by administration of an overdose and testing for shed of vaccine virus and spread to uninoculated sentinel horses; 2) that this vaccine did not become pathogenic once passaged in horses; and 3) vaccine safety under field conditions. METHODS: There were 3 protocols: 1) In the overdose/shed and spread study, horses were vaccinated with a 100x immunogenicity overdose of WN-FV chimera vaccine and housed with sentinel horses. 2) A reversion to virulence study, where horses were vaccinated with a 20x immunogenicity overdose of WN-FV chimera vaccine. Horses in both studies were evaluated for abnormal health conditions and samples obtained to detect virus, seroconversion and dissemination into tissues. 3) In a field safety test 919 healthy horses of various ages, breeds and sex were used. RESULTS: Vaccination did not result in site or systemic reactions in either experimental or field-injected horses. There was no shed of vaccine virus, no detection of vaccine virus into tissue and no reversion to virulence with passage. CONCLUSIONS: WN-FV chimera vaccine is safe to use in horses with no evidence of ill effects from very high doses of vaccine. There was no evidence of reversion to virulence. In addition, administration of this vaccine to several hundred horses that may have been previously exposed to WNV or WNV vaccine resulted in no untoward reactions. POTENTIAL RELEVANCE: These studies establish that this live attenuated Flavivirus chimera is safe to use for immunoprophylaxis against WNV disease in horses. 相似文献
10.
Long MT Gibbs EP Mellencamp MW Bowen RA Seino KK Zhang S Beachboard SE Humphrey PP 《Equine veterinary journal》2007,39(6):491-497
REASON FOR PERFORMING STUDY: West Nile virus (WNF) is a Flavivirus responsible for a life-threatening neurological disease in man and horses. Development of improved vaccines against Flavivirus infections is therefore important. OBJECTIVES: To establish that a single immunogenicity dose of live Flavivirus chimera (WN-FV) vaccine protects horses from the disease and it induces a protective immune response, and to determine the duration of the protective immunity. METHODS: Clinical signs were compared between vaccinated (VACC) and control (CTRL) horses after an intrathecal WNV challenge given at 10 or 28 days, or 12 months post vaccination. RESULTS: Challenge of horses in the immunogenicity study at Day 28 post vaccination resulted in severe clinical signs of WNV infection in 10/10 control (CTRL) compared to 1/20 vaccinated (VACC) horses (P<0.01). None of the VACC horses developed viraemia and minimal histopathology was noted. Duration of immunity (DPI) was established at 12 months post vaccination. Eight of 10 CTRL exhibited severe clinical signs of infection compared to 1 of 9 VACC horses (P<0.05). There was a significant reduction in the occurrence of viraemia and histopathology lesion in VACC horses relative to CTRL horses. Horses challenged at Day 10 post vaccination experienced moderate or severe clinical signs of WNV infection in 3/3 CTRL compared to 5/6 VACC horses (P<0.05). CONCLUSIONS: This novel WN-FV chimera vaccine generates a protective immune response to WNV infection in horses that is demonstrated 10 days after a single vaccination and lasts for up to one year. POTENTIAL RELEVANCE: This is the first USDA licensed equine WNV vaccine to utilise a severe challenge model that produces the same WNV disease observed under field conditions to obtain a label claim for prevention of viraemia and aid in the prevention of WNV disease and encephalitis with a duration of immunity of 12 months. 相似文献